These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21654498)

  • 1. CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts.
    Wright ST; Carr A; Woolley I; Giles M; Hoy J; Cooper DA; Law MG;
    J Acquir Immune Defic Syndr; 2011 Sep; 58(1):72-9. PubMed ID: 21654498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.
    Moore DM; Harris R; Lima V; Hogg B; May M; Yip B; Justice A; Mocroft A; Reiss P; Lampe F; Chêne G; Costagliola D; Elzi L; Mugavero MJ; Monforte AD; Sabin C; Podzamczer D; Fätkenheuer G; Staszewski S; Gill J; Sterne JA;
    J Acquir Immune Defic Syndr; 2009 Nov; 52(3):357-63. PubMed ID: 19668084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.
    Rajasuriar R; Gouillou M; Spelman T; Read T; Hoy J; Law M; Cameron PU; Petoumenos K; Lewin SR
    PLoS One; 2011; 6(6):e20713. PubMed ID: 21674057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial.
    Watts DH; Brown ER; Maldonado Y; Herron C; Chipato T; Reddy L; Moodley D; Nakabiito C; Manji K; Fawzi W; George K; Richardson P; Zwerski S; Coovadia H; Fowler M;
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):299-306. PubMed ID: 23846568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy.
    Li X; Margolick JB; Jamieson BD; Rinaldo CR; Phair JP; Jacobson LP
    J Acquir Immune Defic Syndr; 2011 Aug; 57(5):421-8. PubMed ID: 21602699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database.
    Zhou J; Sirisanthana T; Kiertiburanakul S; Chen YM; Han N; Lim PL; Kumarasamy N; Choi JY; Merati TP; Yunihastuti E; Oka S; Kamarulzaman A; Phanuphak P; Lee CK; Li PC; Pujari S; Saphonn V; Law MG
    BMC Infect Dis; 2010 Dec; 10():361. PubMed ID: 21182796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.
    Amogne W; Aderaye G; Habtewold A; Yimer G; Makonnen E; Worku A; Sonnerborg A; Aklillu E; Lindquist L
    PLoS One; 2015; 10(5):e0122587. PubMed ID: 25966339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study.
    Hughes RA; Sterne JA; Walsh J; Bansi L; Gilson R; Orkin C; Hill T; Ainsworth J; Anderson J; Gompels M; Dunn D; Johnson MA; Phillips AN; Pillay D; Leen C; Easterbrook P; Gazzard B; Fisher M; Sabin CA
    HIV Med; 2011 Nov; 12(10):583-93. PubMed ID: 21569188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD).
    Egger S; Petoumenos K; Kamarulzaman A; Hoy J; Sungkanuparph S; Chuah J; Falster K; Zhou J; Law MG;
    J Acquir Immune Defic Syndr; 2009 Apr; 50(5):513-20. PubMed ID: 19408354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition.
    Mossdorf E; Stoeckle M; Mwaigomole EG; Chiweka E; Kibatala PL; Geubbels E; Urassa H; Abdulla S; Elzi L; Tanner M; Furrer H; Hatz C; Battegay M
    BMC Infect Dis; 2011 Apr; 11():98. PubMed ID: 21504595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
    Cingolani A; Cozzi Lepri A; Castagna A; Goletti D; De Luca A; Scarpellini P; Fanti I; Antinori A; d'Arminio Monforte A; Girardi E
    Clin Infect Dis; 2012 Mar; 54(6):853-61. PubMed ID: 22157323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
    Mocroft A; Phillips AN; Gatell J; Ledergerber B; Fisher M; Clumeck N; Losso M; Lazzarin A; Fatkenheuer G; Lundgren JD;
    Lancet; 2007 Aug; 370(9585):407-13. PubMed ID: 17659333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
    del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Lodi S; van Sighem A; de Wolf W; Sabin C; Bansi L; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Toulomi G; Gargalianos P; Costagliola D; Abgrall S; Hernán MA;
    Clin Infect Dis; 2012 May; 54(9):1364-72. PubMed ID: 22460971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection.
    Prebensen C; Ueland T; Michelsen AE; Lind A; Pettersen FO; Mollnes TE; Aukrust P; Dyrhol-Riise AM; Kvale D
    J Acquir Immune Defic Syndr; 2015 Aug; 69(4):395-402. PubMed ID: 26115437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience.
    Wright ST; Petoumenos K; Boyd M; Carr A; Downing S; O'Connor CC; Grotowski M; Law MG;
    HIV Med; 2013 Apr; 14(4):208-16. PubMed ID: 23036045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.
    Panayidou K; Davies MA; Anderegg N; Egger M;
    J Int AIDS Soc; 2018 Nov; 21(11):e25200. PubMed ID: 30614622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy.
    Lacombe JM; Boue F; Grabar S; Viget N; Gazaignes S; Lascaux-Cametz AS; Pacanowski J; Partisani M; Launay O; Matheron S; Rosenthal E; Rouveix E; Tattevin P; de Truchis P; Costagliola D; Goedert JJ
    AIDS; 2013 Feb; 27(4):635-43. PubMed ID: 23196937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression.
    Ahn JY; Boettiger D; Law M; Kumarasamy N; Yunihastuti E; Chaiwarith R; Lee MP; Sim BL; Oka S; Wong W; Kamarulzaman A; Kantipong P; Phanuphak P; Ng OT; Kiertiburanakul S; Zhang F; Pujari S; Ditangco R; Ratanasuwan W; Merati TP; Saphonn V; Sohn AH; Choi JY;
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):e85-92. PubMed ID: 25850606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.